Symbol="TCON"
AssetType="Common Stock"
Name="TRACON Pharmaceuticals Inc"
Description="TRACON Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for cancer and age-related macular degeneration and fibrotic diseases in the United States. The company is headquartered in San Diego, California."
CIK="1394319"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="4350 LA JOLLA VILLAGE DRIVE, SUITE 800, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="6620300"
EBITDA="-25746000"
PERatio="None"
PEGRatio="0"
BookValue="-0.461"
DividendPerShare="0"
DividendYield="0"
EPS="-1.23"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-1.184"
ReturnOnEquityTTM="-12.77"
RevenueTTM="0"
GrossProfitTTM="-13888000"
DilutedEPSTTM="-1.23"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="5.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="109.39"
PriceToBookRatio="11.83"
EVToRevenue="77.05"
EVToEBITDA="-0.698"
Beta="1.201"
num_52WeekHigh="2.19"
num_52WeekLow="0.19"
num_50DayMovingAverage="0.363"
num_200DayMovingAverage="1.157"
SharesOutstanding="26481300"
DividendDate="2019-11-08"
ExDividendDate="None"
symbol="TCON"
open="0.23"
high="0.25"
low="0.23"
price="0.23"
volume="739852.00"
latest_trading_day="2023-08-18"
previous_close="0.20"
change="0.03"
change_percent="12.1951%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="82"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="18"
Volume_recent_avg="372711"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-2.7"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="18"
Aroon_momentum_negative="82"
image_negative_thumbnail_id_1="503"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0102.jpeg"
image_negative_thumbnail_id_2="1119"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0152.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="592"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_positive_thumbnail_id_1="640"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0068.jpeg"
image_positive_thumbnail_id_2="968"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0130.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
